Stock listing

Memphasys Ltd

Selected listing: MEM · ASX · AUD · AU

Memphasys Ltd (ASX:MEM), Health Technology. Latest release Sep 29, 2026: Memphasys receives A$3.5 million from Peters Investments.

MEM:ASXAUDAUUpdated October 2, 2026

Ticker: ASX:MEM
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: ASX
Currency: AUD

About Memphasys Ltd

The company focuses on developing innovative technologies in the field of reproductive health. Memphasys aims to enhance the efficiency of assisted reproductive technologies through its proprietary solutions.

Latest news from Memphasys Ltd

Memphasys receives A$3.5 million from Peters Investments

September 28, 2026

Potential Expedited FDA Pathway to US IVF Market

September 24, 2026

Memphasys Secures European Felix Agreement

September 17, 2026

Felix Registration Achieved in Turkey, Sales Commence

September 2, 2026

EUR526,500 Nordic Agreement Expands Felix European Footprint

August 31, 2026

All Memphasys Ltd news →

Research Memphasys Ltd

Memphasys Ltd company profile

View the public company page for Memphasys Ltd on 6ix.

Memphasys Ltd news

Read company news and market updates connected to Memphasys Ltd.

Memphasys Ltd investor events

Find investor webinars, events, and replay context for Memphasys Ltd.